Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO 2019 Congress

Molecular tumour board: Where do we stand? What’s next?

Tissue and liquid biopsies with MTB for phase 1 trial selection: Experience in the TARGET trial

Date

29 Sep 2019

Session

Molecular tumour board: Where do we stand? What’s next?

Topics

Clinical Research;  Targeted Therapy;  Translational Research

Tumour Site

Presenters

Matthew Krebs

Authors

M.G. Krebs

Author affiliations

  • Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, M20 4BX - Manchester/GB

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.